In just concluded Meeting of Board of Directors, the Board approved and considered the following items:1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30, 2024.2. Limited Review Reports from the Statutory Auditors on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30, 2024 (annexed herewith).We hereby submit that the Board meeting had commenced at 4.00 PM and concluded at 11.00 PM.The intimation is also being uploaded at Company website: www.gennexlab.comWe request you to take the above information on record and acknowledge receipt of the same.